Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Vistagen Therap. Com (VTGN)

0.93 -0.15 (-13.89%)

04-20 16:00

Open:

0.95

Pre. Close:

1.08

High:

0.98

Low:

0.88

Volume:

1,224,044

Market Cap:

21M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.981 - 0.988

0.988 - 0.994

Low:

0.863 - 0.872

0.872 - 0.879

Close:

0.918 - 0.93

0.93 - 0.939

Technical analysis  (as of: 2018-04-20 4:34:43 PM)

Overall:

      

Stoxline posted a STRONG SELL today, same as yesterday. This stock still seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 1.39     One year: 1.62

Support:

Support1: 0.86    Support2: 0.72

Resistance:

Resistance1: 1.19    Resistance2: 1.39

Pivot:

1.05

Moving Averages:

MA(5): 1.10     MA(20): 1.03

MA(100): 1.18     MA(250): 1.46

MACD:

MACD(12,26): -0.03     Signal(12,26,9): -0.03

%K %D:

%K(14,3): 55.21     %D(3): 75.59

RSI:

RSI(14): 36.17

52-Week:

High: 2.65  Low: 0.69  Change(%): -51.8

Average Vol(K):

3-Month: 53840  10-Days 31851

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
VTGN has closed above bottom band by 15.5%. Bollinger Bands are 41% narrower than normal. The narrow width of the bands suggests low volatility as compared to VTGN's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-04-20T12:55:22-04:00
Midday Gainers / Losers (04/20/2018)

2018-04-20T11:39:29-04:00
Vistagen down 11% on mixed esketamine data

2018-04-20T09:17:06-04:00
Premarket Losers as of 9:05 am (04/20/2018)

2018-04-06T11:18:40-04:00
Your Daily Pharma Scoop: Conatus Setback, Applied DNA Signs Agreement, Evolus Announces Results From Late-Stage Study

2018-04-05T08:45:23-04:00
VistaGen Therapeutics initiates Phase 2 study of AV-101 for MDD

2018-03-21T13:49:04-04:00
Vistagen - Nanocap CNS Drug Chasing Ketamine Fame

2018-03-16T10:25:46-04:00
Key events next week - healthcare

2018-03-09T11:51:14-05:00
Your Daily Pharma Scoop: Progenics Rallies, Merck To Partner With Eisai, Teva Upsizes Debt Offering

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biopharmaceuticals

Shares Out. (M)

22.90

Shares Float (M)

21.46

% Held by Insiders

6.30

% Held by Institutions

32.30

Shares Short (K)

1636

Shares Short Prior Month (K)

350

Stock Financials

EPS

-1.360

EPS Est. Current Year

-1.990

EPS Est. Next Year

-0.900

EPS Est. Next Quarter

Forward EPS

-1.900

Book Value (p.s.)

2.340

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-139.4

Return on Equity (ttm)

-218.3

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.439

Qtrly Earnings Growth

Operating Cash Flow (M)

-7.75

Levered Free Cash Flow (M)

-4.53

atoplab.com

Valuation

P/E

-0.68

P/E Growth Ratio

-0.14

P/BV

0.40

P/S

P/CF

-2.75

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2014-08-14

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.